1.
The Dysregulation of mir-21 and mir-143 as a clinical Marker for Cancer Stem Cells in Tissue Samples of Iraqi Male Patients with Gastrointestinal Sarcoma. Journal of Pharmaceutical Negative Results [Internet]. 2022 Sep. 20 [cited 2024 Jul. 15];13(3):20-5. Available from: https://pnrjournal.com/index.php/home/article/view/217